Corpus ID: 27610936

[Basic research on nedocromil sodium].

@article{Joseph1992BasicRO,
  title={[Basic research on nedocromil sodium].},
  author={M. Joseph and D. Rainey},
  journal={Revue des maladies respiratoires},
  year={1992},
  volume={9 Suppl 1},
  pages={
          R93-7
        }
}
Nedocromil sodium is a new chemical entity. This compound is very hydrophilic and is well absorbed by tissues such as the lung but not by tissues with tight junctions such as the gut. This product is chemically different from all drugs currently used for the treatment of airway diseases. The in vitro effects of nedocromil sodium are reviewed. Nedocromil sodium is capable of blocking: 1) the chemotaxis of neutrophils; 2) the activation of macrophages and monocytes by IgE; 3) the release of… Expand
Mast Cells Involvement in the Inflammation and Fibrosis Development of the TNBS-induced Rat Model of Colitis
TLDR
Mast cells are involved in the gastrointestinal tract inflammation and fibrosis of the TNBS-colitis rats as well as in chronic inflammatory conditions resulting in fibrosis, such as Crohn disease. Expand
The Anti-allergic Cromones: Past, Present, and Future
TLDR
The history of these drugs are reviewed, some aspects of their pharmacology are recounted, and two new explanations for their unique actions are discussed, which are suggested to be used to predict further uses for the cromones. Expand
Group Comparative Trial of 2% Nedocromil Sodium with Placebo in the Treatment of Seasonal Allergic Conjunctivitis
A double blind group comparative trial comparing 2% nedocromil sodium with placebo in treating seasonal allergic conjunctivitis over a four week period is reported. Sixty-four patients were analysed.Expand
Cromoglycate drugs suppress eicosanoid generation in U937 cells by promoting the release of Anx-A1
Graphical abstract